Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
. Your work will be central to achieving the project’s ambitious academic, industrial and societal impact goals. DTU Construct is seeking a Postdoc to develop robust metrics and data collection methods
-
Confederation of Professional Associations. The allowance will be agreed upon with the relevant union. The period of employment is 1 year. You can read more about career paths at DTU here . Further information
-
research frameworks developed at DTU Integrate product data, regulation, and stakeholder needs into tailored solutions Address behavioural, incentive, and digital aspects of take-back design Collaborate
-
. The allowance will be agreed upon with the relevant union. The period of employment is 1 year. You can read more about career paths at DTU here . Further information Further information may be obtained from
-
related area (mandatory). Ability to independently conduct liquid chromatography-mass spectrometry (LC-MS)-based peptide analysis/proteomics, including proficiency in related data processing software
-
Job Description If you are passionate about data analytics, numerical modelling and marine research, we have an opportunity for you! DTU Aqua invites applications for a two-year postdoctoral
-
here . Further information Further information may be obtained from Daniela Pigosso (danpi@dtu.dk ). You can read more about DTU Construct at www.construct.dtu.dk, and the Section of Design for
-
here . Further information Further information may be obtained from Venkata Nadimpalli (vkna@dtu.dk ) or Jesper Hattel (jhat@dtu.dk ). You can read more about DTU Construct at www.construct.dtu.dk, and
-
oxygen delivery - without relying on human donors. You’ll build on the 3Bs group's extensive data and recent publications to evaluate the biological performance of these nanocarriers in preclinical models
-
oxygen delivery—without relying on human donors. You’ll build on the 3Bs group's extensive data and recent publications to evaluate the biological performance of these nanocarriers in preclinical models